[HTML][HTML] Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB

T Xu, P Guo, C Pi, Y He, H Yang, Y Hou, X Feng… - Journal of …, 2020 - ncbi.nlm.nih.gov
Curcumin (CU) has shown broad anti-cancer effects. 5-fluorouracil (5-FU) has been a
conventional chemotherapeutic agent for hepatocellular carcinoma. Unfortunately, the …

[HTML][HTML] Induction of apoptosis and proliferation inhibition of hepatocellular carcinoma by 6-chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA): in vitro and vivo …

Y Huang, G Liu, F Yang, X Xing, Y Li, Z Huang… - Cancer Cell …, 2017 - Springer
Abstract Background 6-Chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA), a novel
sponge-derived compound, has been reported to elicit a cytotoxic effect by inhibiting cell …

[HTML][HTML] ERK1/2 通路对Genistein 与5-FU 诱导的人肝癌细胞周期阻滞的影响

刘丹, 赵忠新, 迟大鹏, 梅庆步, 于海涛, 岳丽玲… - 世界华人消化 …, 2014 - wjgnet.com
ERK1/2通路对Genistein与5-FU诱导的人肝癌细胞周期阻滞的影响 主页 简体中文 English 简体
中文 登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人 …

Prospettive di terapia sistemica combinata sorafenib+ capecitabina per l'epatocarcinoma. Valutazione nel modello animale e ruolo dell'imaging ad ultrasuoni

L Venerandi - 2015 - amsdottorato.unibo.it
Il Sorafenib è l'unica terapia sistemica approvata per l'epatocarcinoma (HCC) avanzato.
Tuttavia, molti tumori sviluppano resistenze. La chemioterapia metronomica sembrerebbe …